AngioDynamics executive bonuses reach 180% of target
Fiscal 2026 annual incentive payouts were 180% of target for each named executive officer, based on financial metrics and corporate objectives.
Filing Impact
(Neutral)
Filing Sentiment
(Neutral)How Sentiment works
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
How Sentiment worksHow the balance works
Rhea-AI Filing Summary
AngioDynamics, Inc. amended its fiscal 2026 annual report to add Part III disclosures on directors, governance and executive <a href="https://bitcomme.com/group-5-releases-2026-equity-compensation-administration-benchmarking-study-results/” title=”Group 5 Releases 2026 Equity Compensation Administration Benchmarking Study Results”>compensation. It states that no other items were amended or updated and that the original report otherwise remains unchanged.
For fiscal 2026, net sales were $320.2 million against a $312 million incentive target, and Adjusted EBITDA was $18.2 million against a $10.5 million target. Each of the five named executive officers received an annual cash incentive payout equal to 180% of target. Approximately 93.1% of votes cast, including abstentions, favored named executive compensation at the 2025 annual meeting; the committee kept its general approach for fiscal 2026.
Chief Executive Officer James C. Clemmer announced an intention to retire on the earlier of November 30, 2026, or the appointment of a successor, with a possible month-to-month extension by mutual agreement. Retention agreements provide Stephen A. Trowbridge, Laura Piccinini and Warren G. Nighan awards equal to 150% of base salary if they meet the stated employment condition or their position is eliminated without cause; other executive leadership team members are eligible for 50%.
